CEACAM5 and colorectal carcinoma: The multiple survival analysis, including known clinical parameters, serum CEA, and the three plasma miRNAs, revealed that stage, serum CEA, plasma miR-200b (P = 0.008, risk ratio (RR) = 2.630), and miR-96 (P = 0.019, RR = 2.275) were independent factors for overall survival of CRC patients (Table 2).